"Designing Growth Strategies is in our DNA"

Anti Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and Regional Forecast, 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI101188

 


To get information on various segments, share your queries with us

 ATTRIBIUTE

 DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD billion)

Segmentation

By Drug Type

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines

By Indication

  • Dermatophytosis
  • Candidiasis
  • Aspergillosis
  • Others

By Route of Administration

  • Oral
  • Topical
  • Parenteral

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

By Geography

  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (IN PROCESS)
  • 2024
    (IN PROCESS)
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann